Finally, in patients with CAD, we compared the prognostic value of SR-BI-mediated cholesterol efflux with variables previously found to be independently associated with clinical events, such as non-calcified atherosclerotic plaque (NCP) volume >80 mm3 and Framingham risk score (FRS) >20% [32]. This evidence concerns the gene SCARB1 and coronary artery disorder.